UK
Vectura agree £441m merger with Skyepharma
March 16, 2016Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura
Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …
New web portal highlights UK strengths in medicines manufacturing
December 1, 2015Manufacturing and Production ABPI, KTN, Knowledge Transfer Network, Medicines Manufacturing Industry Partnership, UK, manufacturing, mmip, production
A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines …
North of England secures new ‘centres of excellence’ in ‘precision medicine’
October 27, 2015Manufacturing and Production, Research and Development NHS, Northern Health Science Alliance, UK
The umbrella group formed by the leading northern universities, teaching hospitals and Academic Health Science Networks – the Northern Health …
Doctors ‘distrust apps developed by pharma’ – survey
July 31, 2015Medical Communications France, GPs, Germany, Healthcare Technologies, UK, chronic disease, disease management, healthcare tech
A study of GPs in three European countries show GPs feel there is a role for healthcare technologies in disease …
Government launches Accelerated Access Review call to action
July 14, 2015Research and Development Accelerated Access Review, Sir Hugh Taylor, UK, george freeman, john bell, life sciences minister
The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …
Chancellor announces drug R&D funding boost in Catapult expansion
July 14, 2015Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy
Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …
Prices to be printed on all prescribed NHS drugs over £20
July 2, 2015Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines
NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …
UK Court weighs in on Lilly-Actavis Alimta case
June 26, 2015Medical Communications, Sales and Marketing Actavis, Alimta, UK, lilly
Actavis will be infringing Lilly’s patent if it were to produce generic versions of Alimta, the UK Court of Appeal …
NICE reworks cancer guidance for GPs
June 23, 2015Sales and Marketing Cancer, GPs, NICE, UK, baker, research
The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …
NICE wants more answers from Gilead on Zydelig
June 18, 2015Sales and Marketing Gilead, MabThera, NICE, Roche, UK, brett wells, zydelig
The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance. But the …
Cameron restates £8 billion NHS funding plans
May 18, 2015Sales and Marketing BMA, Cameron, NHS, UK
UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …
Pharma accused of hiding behind regulation and undermining NICE
April 29, 2015Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma
University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …
Cancer Research Technology and Medivir to develop new class of cancer drugs
April 13, 2015Research and Development, Sales and Marketing Medivir, UK, adam8, cancer research technology, oncology
Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …
Refining UK market access
April 7, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access
“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …
Big pharma teams with government on genomic research
March 27, 2015Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes
Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
